These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 33892489
1. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Fox KAA, Virdone S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Oto A, Misselwitz F, Piccini JP, Dalgaard F, Turpie AGG, Verheugt FWA, Kakkar AK, GARFIELD-AF Investigators. Eur Heart J Qual Care Clin Outcomes; 2022 Mar 02; 8(2):214-227. PubMed ID: 33892489 [Abstract] [Full Text] [Related]
2. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. Fox KAA, Lucas JE, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Oto A, Mantovani LG, Misselwitz F, Piccini JP, Turpie AGG, Verheugt FWA, Kakkar AK, GARFIELD-AF Investigators. BMJ Open; 2017 Dec 21; 7(12):e017157. PubMed ID: 29273652 [Abstract] [Full Text] [Related]
3. GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study. Dalgaard F, Pieper K, Verheugt F, Camm AJ, Fox KA, Kakkar AK, Pallisgaard JL, Rasmussen PV, Weert HV, Lindhardt TB, Torp-Pedersen C, Gislason GH, Ruwald MH, Harskamp RE. BMJ Open; 2019 Nov 11; 9(11):e033283. PubMed ID: 31719095 [Abstract] [Full Text] [Related]
4. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA, GARFIELD-AF, ORBIT-AF Investigators. Am Heart J; 2017 Dec 11; 194():132-140. PubMed ID: 29223431 [Abstract] [Full Text] [Related]
12. [A comparison of CAS risk model and CHA2DS2-VASc risk model in guiding anticoagulation treatment in Chinese patients with non-valvular atrial fibrillation]. Deng JL, He L, Jiang C, Lai YW, Long DY, Sang CH, Jia CQ, Feng L, Li X, Ning M, Hu R, Dong JZ, Du X, Tang RB, Ma CS. Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep 24; 50(9):888-894. PubMed ID: 36096706 [Abstract] [Full Text] [Related]
13. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Serna MJ, Rivera-Caravaca JM, López-Gálvez R, Soler-Espejo E, Lip GYH, Marín F, Roldán V. Rev Esp Cardiol (Engl Ed); 2024 Oct 24; 77(10):835-842. PubMed ID: 38460882 [Abstract] [Full Text] [Related]
14. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry. Apenteng PN, Gao H, Hobbs FR, Fitzmaurice DA, UK GARFIELD-AF Investigators and GARFIELD-AF Steering Committee. BMJ Open; 2018 Jan 13; 8(1):e018905. PubMed ID: 29331969 [Abstract] [Full Text] [Related]
15. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48. Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA. Circulation; 2019 Feb 05; 139(6):760-771. PubMed ID: 30586727 [Abstract] [Full Text] [Related]